Ascidian Toxins with Potential for Drug Development

Mar Drugs. 2018 May 13;16(5):162. doi: 10.3390/md16050162.

Abstract

Ascidians (tunicates) are invertebrate chordates, and prolific producers of a wide variety of biologically active secondary metabolites from cyclic peptides to aromatic alkaloids. Several of these compounds have properties which make them candidates for potential new drugs to treat diseases such as cancer. Many of these natural products are not produced by the ascidians themselves, rather by their associated symbionts. This review will focus mainly on the mechanism of action of important classes of cytotoxic molecules isolated from ascidians. These toxins affect DNA transcription, protein translation, drug efflux pumps, signaling pathways and the cytoskeleton. Two ascidian compounds have already found applications in the treatment of cancer and others are being investigated for their potential in cancer, neurodegenerative and other diseases.

Keywords: anticancer activity; bacterial symbiosis; mechanism of action; secondary metabolites.

Publication types

  • Review

MeSH terms

  • Animals
  • Cytoskeleton / drug effects
  • Drug Design*
  • Humans
  • Marine Toxins / pharmacology*
  • Marine Toxins / therapeutic use
  • Marine Toxins / toxicity
  • Neoplasms / drug therapy
  • Neurodegenerative Diseases / drug therapy
  • Protein Biosynthesis / drug effects
  • Signal Transduction / drug effects
  • Transcription, Genetic / drug effects
  • Urochordata / metabolism*

Substances

  • Marine Toxins